Post-Reduction Management and Prevention of Subsequent Fractures in Colles Fracture
Early Mobilization and Rehabilitation
- The American College of Rheumatology recommends beginning range-of-motion exercises for fingers and hand immediately after immobilization to prevent edema and stiffness, and initiating aggressive finger and hand motion exercises when immobilization is discontinued 1
- Early post-fracture physical training and muscle strengthening should be implemented as the patient tolerates, with individual functional goals identified before developing the specific rehabilitation plan 1
Pharmacological Treatment
- The American College of Rheumatology recommends that all patients over 50 with a Colles fracture should be started on oral bisphosphonates (alendronate or risedronate) as first-choice agents, which reduce vertebral fractures by 47-48%, non-vertebral fractures by 26-53%, and hip fractures by 40-51% 4, 5
- Bisphosphonates should be prescribed for 3-5 years initially, with longer duration for patients remaining at high fracture risk, and alternatives such as zoledronic acid or denosumab should be used for patients with oral intolerance or non-compliance 4, 5
Essential Adjunctive Therapy
- The American College of Rheumatology recommends that all patients must receive calcium 1000-1200 mg/day plus vitamin D 800 IU/day, which reduces non-vertebral fractures by 15-20% and falls by 20% 4, 5
- Calcium supplementation alone without bisphosphonates has no demonstrated fracture reduction effect and should not be used as monotherapy 5
Systematic Follow-Up Protocol
- A five-step Fracture Liaison Service (FLS) approach should be implemented, including identifying the patient with recent fracture, inviting for fracture risk evaluation, performing differential diagnosis, initiating therapy, and establishing systematic follow-up 4
- A dedicated coordinator should organize diagnostic investigations and interventions under supervision of an orthopedic surgeon or endocrinologist, and monitor regularly for medication tolerance and adherence 3, 4